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Study Group. Duke University Medical Center, Durham, NC. 
In this multicenter trial 575 patients (pts) were randomized in a 
factorial design to 1 of 3 drug regimens (t-PA alone. urokinase 
(UK) done, or both (COMBO)) and I of 2 cardiac catheterization 
strategies (acute vs predischarge). In the acute strategy angioplasty 
was attempted only in pts with an occluded infarct related artery. 
Preliminary analysis of major in-hospital outcomes revealed s trend 
@war& a lower rate of death, reocclusion and recurrent ischemia 
in the COMBO group: 
t-PA UK COMBO 
Death 
(N;l$) (N$‘G) (N=;t) 
‘Reocclusion 12% 8% 2% 
Recurrent ischemia :iZ+ 23% 17% 
Heart Failure 15% 15% 
*Acute cath group Only 
‘When acute and pre-discharge cath strategies were compared, a 
trend towards higher mortality, but less heart failure and recurrent 
war seen in the acute group: 
Acute Pre-discharge 
Dtath 
(N;t7) W-3 
Recurrent ischemir 16% 26% 
Heart hilure 13% 17% 
22 unitt transfusion 11% 10% 
(CGlkSUx~iCd) 
Final analyses will examine left ventricular function, clinical 
outcomes and cost in an evaluation of all 6 possible strategies. 
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Atria1 natrluretic peptide (ANP) Is synthesized and 
released mainly by atria1 cardiocytea in response to 
atria1 wall distension. The aRNA of ARP has been 
detected fror atria1 extracts but fts cellular 
distribution hii en studied. e Investigated the 
distributions o 
RNA-RNA tissue 
imwunocytochemistry respectively, on consecutive 
sections of rat atria (n=12). A warRed difference in 
quantitative distributions between the two components 
unoreactlvity is located in 
ules which are distributed in 
all atria3 cardiomyocytes In about even numbers, ANP 
mRNA is present mainly in the layer of cardioayocytes 
adjacent to the endocardium and that to the epicardium. 
less ARP mRNA. The specificities of both techniques used 
were established with approgriate controls. These 
findings suggest that ANP gene is expressed more 
vigorously in the a,crial cardioayocytes located directly 
adjacent to the endocardial and those to the epicardial 
surface of the atria1 wail than the other 
cardiomyocytee. This indicates the cardio 
located adjacent to the internal and the external 
superficial layers of the atria synthesize and release 
significantly core ANP than the other cells. We 
hypothesize that there are two cell types in ihe atria 
based on their different abilities to express ANP gene. 
